Mirum Pharmaceuticals, Inc.
MIRM
$43.42
-$0.03-0.07%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -87.94M | -99.81M | -109.16M | -158.56M | -163.42M |
| Total Depreciation and Amortization | 24.98M | 24.20M | 20.59M | 15.78M | 11.45M |
| Total Amortization of Deferred Charges | 1.66M | 1.64M | 1.63M | 1.53M | 1.12M |
| Total Other Non-Cash Items | 49.03M | 55.92M | 55.67M | 99.16M | 99.13M |
| Change in Net Operating Assets | 22.59M | 16.83M | 7.85M | 5.14M | -19.22M |
| Cash from Operations | 10.33M | -1.23M | -23.43M | -36.96M | -70.94M |
| Capital Expenditure | -993.00K | -973.00K | -792.00K | -81.00K | -109.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 0.00 | -212.76M | -212.76M | -212.76M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -89.13M | -91.79M | -43.94M | 78.62M | 105.67M |
| Cash from Investing | -90.13M | -92.77M | -257.49M | -134.23M | -107.20M |
| Total Debt Issued | -- | 0.00 | 0.00 | 305.30M | 305.30M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 17.70M | 14.42M | 217.68M | 212.49M | 227.15M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -281.00K | -281.00K | -192.98M | -195.86M |
| Cash from Financing | 17.70M | 14.14M | 217.40M | 324.82M | 336.60M |
| Foreign Exchange rate Adjustments | -1.30M | 190.00K | -213.00K | -208.00K | -133.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -63.40M | -79.67M | -63.73M | 153.42M | 158.32M |